Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Revised FDA Rules regarding Orange Book Listings under the Hatch-Waxman Act

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Other

First published online October, 2003

Revised FDA Rules regarding Orange Book Listings under the Hatch-Waxman Act

Volume 1, Issue 1

https://doi.org/10.1057/palgrave.jgm.4940020

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Strategic use of Supplementary Protection Certificates (Part 2)

Retricted access

Bayer Healthcare Pharmaceuticals,Inc. v. Watson Pharmaceuticals,Inc. : Was the decision to selectively present evidence of commercial success too “clever by half”?

Retricted access

Introduction to the America Invents Act

Retricted access

Palmetto v. AstraZeneca : The scope of intent as a claim element